Vectors derived from adeno-associated viruses (AAV) have been generated using numerous naturally occurring and synthetic serotypes of the virus. Such vectors have proven to be extremely useful for a variety of gene transfer studies, both in vitro and in vivo, and are increasingly being used in gene therapy protocols for a variety of human disorders. Methods to produce AAV vectors typically rely on co-transfection of several different plasmid vectors that carry the transgene of interest (the gene to be delivered, in a “transfer plasmid”) and helper genes needed for AAV vector replication and packaging (helper plasmids). While the methods used to generate AAV are conceptually simple, minor variations in a variety of steps can result in significant differences in the overall yield of vector. Here we describe protocols for generating vectors derived from AAV6, which are particularly useful for gene transfer to muscle tissues.
CITATION STYLE
Halbert, C. L., Allen, J. M., & Chamberlain, J. S. (2018). AAV6 vector production and purification for muscle gene therapy. In Methods in Molecular Biology (Vol. 1687, pp. 257–266). Humana Press Inc. https://doi.org/10.1007/978-1-4939-7374-3_18
Mendeley helps you to discover research relevant for your work.